Contineum (CTNM) announced authorization of its investigational new drug, or IND, application from FDA for PIPE-791 for the treatment of chronic pain associated with two separate indications, ...
There are four stages of osteoarthritis (OA): early, mild, moderate, and severe. You can also be diagnosed with a stage called pre-osteoarthritis. OA is a progressive joint disease caused by cartilage ...
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...
Osteoarthritis is considered a risk factor for severe cardiovascular disease like ischemic heart disease and myocardial infarction. Studying ~60 000 twins over a 20-year period and applying ...
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...